Novartis To Acquire IFM Tre In $1.575 Billion Deal To Develop NLRP3
Posted by
www.biotecnika.org
Novartis To Acquire IFM Tre In $1.575 Billion Deal To Develop NLRP3
IFM Therapeutics (IFM) on 1st April 2019 announced its pact with
Novartis wherein Novartis will acquire capital stock of IFM Tre, a
subsidiary company of IFM which was launched in July 2018 focused on
developing antagonists for treating inflammatory diseases. IFM is a
private biopharmaceutical […]
The post Novartis To Acquire IFM Tre In $1.575 Billion Deal To Develop
NLRP3 appeared first on BioTecNika .
https://www.biotecnika.org/2019/04/novartis-acquire-ifm-tre-1-575-billion-deal/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment